Detalhe da pesquisa
1.
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.
Gastroenterology
; 143(6): 1576-1585.e4, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22929808
2.
Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy.
Am J Gastroenterol
; 108(7): 1112-22, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23732467
3.
Fibrosis progression in HCV carriers with mild hepatitis who possess the high-repetition variant of the DRD4 gene, a genetic marker for binge-drinking and risk-seeking behavior: a longitudinal study.
Alcohol Clin Exp Res
; 37(6): 891-5, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23298155
4.
The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases.
J Med Virol
; 84(5): 747-55, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22431022
5.
Apolipoprotein E genotypes modulate fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases.
J Gastroenterol Hepatol
; 26(2): 328-33, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21261723
6.
The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naïve hepatitis C patients.
Hepatology
; 49(5): 1460-8, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19353740
7.
Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C.
Hum Immunol
; 71(10): 999-1004, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20655350
8.
Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study.
Am J Gastroenterol
; 99(5): 855-9, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15128350